Sunrest Lifescience Limited (NSE:SUNREST)
India · Delayed Price · Currency is INR 33.90
0.00 (0.00%)
Jun 12, 2026, 12:55 PM IST
Sunrest Lifescience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 708.33 | 334.13 | 294.83 | 246.42 | 268.88 | |
Revenue Growth (YoY) | 111.99% | 13.33% | 19.65% | -8.35% | 58.64% |
Cost of Revenue | 442.54 | 200.78 | 199.88 | 148.78 | 174.62 |
Gross Profit | 265.79 | 133.36 | 94.95 | 97.65 | 94.25 |
Selling, General & Admin | 76.11 | 50.07 | 39.69 | 33.28 | 26.62 |
Other Operating Expenses | 62.55 | 53.05 | 46.18 | 35.03 | 56.52 |
Operating Expenses | 150.58 | 104.08 | 86.84 | 69.61 | 83.74 |
Operating Income | 115.22 | 29.28 | 8.11 | 28.03 | 10.51 |
Interest Expense | -14.18 | -2.89 | -0.65 | -0.59 | -0.23 |
Interest & Investment Income | - | 0.01 | - | - | - |
Other Non Operating Income (Expenses) | -0 | -0.17 | -1.53 | -0 | - |
EBT Excluding Unusual Items | 101.03 | 26.23 | 5.93 | 27.44 | 10.28 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.22 |
Pretax Income | 101.03 | 26.23 | 5.93 | 27.44 | 10.5 |
Income Tax Expense | 21.09 | 6.13 | 3.67 | 7.01 | 2.73 |
Earnings From Continuing Operations | 79.94 | 20.11 | 2.26 | 20.43 | 7.77 |
Minority Interest in Earnings | -38.78 | -0.05 | - | - | - |
Net Income | 41.16 | 20.05 | 2.26 | 20.43 | 7.77 |
Net Income to Common | 41.16 | 20.05 | 2.26 | 20.43 | 7.77 |
Net Income Growth | 105.27% | 788.48% | -88.95% | 162.91% | 369.55% |
Shares Outstanding (Basic) | 4 | 4 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 4 | 4 | 3 | 3 | 3 |
Shares Change (YoY) | - | 29.14% | 10.77% | - | - |
EPS (Basic) | 9.59 | 4.67 | 0.68 | 6.81 | 2.59 |
EPS (Diluted) | 9.59 | 4.67 | 0.68 | 6.81 | 2.59 |
EPS Growth | 105.35% | 587.57% | -90.03% | 162.93% | 370.91% |
Free Cash Flow | -75.68 | 15.49 | -148.05 | 11.41 | -9.15 |
Free Cash Flow Per Share | -17.64 | 3.61 | -44.55 | 3.80 | -3.05 |
Gross Margin | 37.52% | 39.91% | 32.20% | 39.63% | 35.05% |
Operating Margin | 16.27% | 8.76% | 2.75% | 11.38% | 3.91% |
Profit Margin | 5.81% | 6.00% | 0.77% | 8.29% | 2.89% |
Free Cash Flow Margin | -10.69% | 4.64% | -50.21% | 4.63% | -3.40% |
EBITDA | 127.14 | 30.23 | 9.09 | 29.33 | 11.11 |
EBITDA Margin | 17.95% | 9.05% | 3.08% | 11.90% | 4.13% |
D&A For EBITDA | 11.92 | 0.95 | 0.97 | 1.3 | 0.6 |
EBIT | 115.22 | 29.28 | 8.11 | 28.03 | 10.51 |
EBIT Margin | 16.27% | 8.76% | 2.75% | 11.38% | 3.91% |
Effective Tax Rate | 20.87% | 23.35% | 61.92% | 25.54% | 26.01% |
Revenue as Reported | 733.4 | 334.18 | 294.84 | 246.71 | 269.1 |